
5 February 2025
Ondo InsurTech Plc
("Ondo" or the "Company")
Exercise of Warrants and Director/PDMR Shareholding
Ondo InsurTech Plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Craig Foster, Chief Executive Officer of the Company, has exercised warrants to subscribe for 889,783 ordinary shares of 5 pence each ("Ordinary Shares") at an exercise price of 25 pence each (the "Warrants") and will be admitted to the Official List under the Ondo block listing.
The Company also announces that Criag Foster has sold 700,000 Ordinary Shares at an average price of 37p per share, the proceeds of which will be applied to meet in part the exercise of the Warrants and the resulting tax liability.
Following the exercise of the Warrants and the sale of Ordinary Shares Craig Foster's interest in the Company has increased by 189,783 Ordinary Shares and he now holds 2,182,341 Ordinary Shares representing 1.7% of the Company's issued share capital.
Enquiries
Ondo InsurTech Plc | Craig Foster, CEO Kevin Withington, CFO | +44 (0) 800 783 9866 |
Dowgate Capital Ltd (Broker & Financial Advisor) | Russell Cook Nick Chambers Charlie Hall | +44 (0) 20 3903 7715
|
Cassiopeia Services Ltd (PR & Investor Relations) | Stefania Barbaglio | +44 (0) 7949 690338
|
The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.
1
| Details of the person discharging managerial responsibilities / person closely associated
| |
a) | Name
| Craig Foster |
2
| Reason for the notification
| |
a)
| Position/status
| Chief Executive Officer and PDMR
|
b)
| Initial notification /Amendment
| Initial Notification |
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a)
| Name
| Ondo InsurTech Plc |
b)
| LEI
| 2138005Y5QBJQMOOI719 |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 5 pence each
ISIN: GB00BNVVGD77 |
b)
| Nature of the transaction
| Exercise of Warrants |
c)
| Price(s) and volume(s)
| Exercise of Warrants over 889,783 Ordinary Shares at an exercise price of 25p per warrant
|
d)
| Aggregated information
|
|
e)
| Date of the transaction
| 5 February 2025 |
f)
| Place of the transaction
| Outside of a trading venue |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a) | Name
| Craig Foster | ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| Chief Executive Officer and PDMR
| ||||||
b)
| Initial notification /Amendment
| Initial Notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| Ondo InsurTech Plc | ||||||
b)
| LEI
| 2138005Y5QBJQMOOI719 | ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Sale of ordinary shares of 5 pence each
ISIN: GB00BNVVGD77 | ||||||
b)
| Nature of the transaction
| Sale of Ordinary Shares | ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information
|
| ||||||
e)
| Date of the transaction
| 31 January 2025 | ||||||
f)
| Place of the transaction
| London Stock Exchange, Main Market (XLON) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.